Real World Experience First Trimester Megacystis Management

Measure LBD and Stratify
LBD 7–15 mm
(Mild to moderate)

LBD >15 mm
(Severe)
This cutoff is critical. Biology shifts at 15 mm.

Pathway A — LBD 7–15 mm
Assess NT
• Normal NT
• Increased NT

If NT Normal
Risk profile:
• High chance spontaneous resolution (70–90%)
• Chromosomal risk ~5–10%
• Obstruction less likely

Management:
• Invasive testing (CMA preferred)
• Early anomaly scan at 14–16 weeks
• Reassess bladder

If resolves by 16 weeks → Prognosis excellent.

If persists → Move to obstruction pathway.

If NT Increased
Now risk shifts toward chromosomal/syndromic.

Management:
• Strongly recommend invasive testing (karyotype + CMA)
• Consider RASopathy testing if NT markedly increased
• Detailed early anatomy scan
• Counsel about higher adverse risk

If genetics normal and bladder resolves → guarded but often good outcome.
If both persist → higher structural risk.

Pathway B — LBD >15 mm
High likelihood:
• Mechanical obstruction
• Posterior urethral valves (if male)
• Urethral atresia

Early Signs of Damage
• Bladder wall thickening
• Bilateral hydronephrosis
• Echogenic kidneys
• Reduced amniotic fluid

Presence of early oligohydramnios before 16 weeks = poor sign.

Follow-Up at 14–16 Weeks
Reassess:
• Bladder size
• Renal appearance
• Amniotic fluid

Persistent Megacystis, Normal AFI
→ Monitor closely
→ Detailed anatomy scan
→ Consider fetal echo
→ Watch for renal deterioration

Persistent + Oligohydramnios
→ High risk renal dysplasia
→ Discuss prognosis early
→ Consider referral to fetal therapy center
→ Possible vesicoamniotic shunt if criteria met

When to Consider Advanced Genetic Testing
Consider RASopathy panel or exome if:
• NT markedly increased
• Multiple anomalies
• Megacystis without clear obstruction
• Female fetus with severe presentation

Counseling

Practical Take-Home
1. <15 mm behaves differently from >15 mm
2. Small megacystis → more genetic
3. Large megacystis → more obstructive
4. Early oligohydramnios predicts poor lung and renal outcome
5. Resolution before 16 weeks dramatically improves prognosis